Amit S Chitnis
Overview
Explore the profile of Amit S Chitnis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wick J, Ni Y, Halmer N, Wong R, Chitnis A, Jaganath D, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae484.
PMID: 39296340
Background: Tuberculosis infection (TBI) and chronic hepatitis B virus (HBV) infection disproportionately affect non-US-born persons. Early identification and treatment are critical to reduce transmission, morbidity, and mortality, but little is...
2.
Yette E, Marusinec R, Conlon C, Pham T, Toy M, So S, et al.
J Public Health Manag Pract
. 2024 Sep;
31(1):116-123.
PMID: 39264250
Context: In the United States, chronic hepatitis B (CHB) virus infection predominantly affects ethnic minorities and vulnerable populations. Objective: We analyzed surveillance data to describe CHB epidemiology to guide hepatitis...
3.
Marusinec R, Clifton T, Chitnis A, Jaganath D
J Clin Tuberc Other Mycobact Dis
. 2024 Sep;
37:100475.
PMID: 39224114
Background: Advanced pulmonary tuberculosis (APT) may reflect delays in tuberculosis (TB) diagnosis and contribute to ongoing disease transmission and poor outcomes. We characterized trends and factors associated with APT over...
4.
Florea A, Pak K, Gounder P, Malden D, Im T, Chitnis A, et al.
J Public Health Manag Pract
. 2024 Jun;
30(6):E270-E281.
PMID: 38936394
Context: Chronic hepatitis B (CHB), caused by hepatitis B virus (HBV), is a risk factor for cirrhosis. The management of HBV-related cirrhosis is challenging, with guidelines recommending treatment initiation and...
5.
Yeoh A, Cheung R, Ahmed A, Chitnis A, Do A, Wong R
Am J Med
. 2023 Dec;
137(1):e15.
PMID: 38061829
No abstract available.
6.
Malden D, Wong R, Chitnis A, Im T, Tartof S
Am J Med
. 2023 Nov;
137(3):258-265.e3.
PMID: 38000687
Background: Hepatitis B virus (HBV) and latent tuberculosis infection are associated with a significant global burden, but both are underdiagnosed and undertreated. We described the screening patterns and risk factors...
7.
Yang Z, Cheung R, Chitnis A, Zhang W, Gish R, Wong R
JHEP Rep
. 2023 Sep;
5(10):100852.
PMID: 37701335
Background & Aims: The vast majority of studies evaluating differences in on-treatment risks of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB) have been conducted in Asia. Data...
8.
Yeoh A, Cheung R, Ahmed A, Chitnis A, Do A, Wong R
Am J Med
. 2023 Mar;
136(7):669-676.e1.
PMID: 37001720
Background: A leading cause of mortality in fatty liver disease is cardiovascular disease. Metabolic dysfunction-associated fatty liver disease (MAFLD) is new terminology that classifies fatty liver due to metabolic dysfunction...
9.
Chen J, Marusinec R, Brown R, Shiau R, Jaganath D, Chitnis A
J Public Health Manag Pract
. 2023 Mar;
29(3):353-360.
PMID: 36867649
Context: Patients with culture-negative pulmonary TB (PTB) can face delays in diagnosis that worsen outcomes and lead to ongoing transmission. An understanding of current trends and characteristics of culture-negative PTB...
10.
Wong R, Rupp L, Lu M, Yang Z, Daida Y, Schmidt M, et al.
J Viral Hepat
. 2023 Feb;
30(6):512-519.
PMID: 36843435
The epidemiology of latent tuberculosis and hepatitis B virus (HBV-LTBI) co-infection among U.S. populations is not well studied. We aim to evaluate LTBI testing patterns and LTBI prevalence among two...